Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Maximize the potential of your data to enhance the experiences of both your clinic and your patients. InSightive converts your oncology data into actionable insights that can be implemented immediately. By normalizing and structuring your data through oncology-specific relationships, you can achieve greater clarity and precision. Utilizing industry-leading Tableau visualization, our platform offers analytics tailored to the oncology field, boosting clinical performance significantly. InSightive can be accessed through ARIA, a standalone desktop application, or virtually any web browser. Kickstart your journey with readily customizable templates that focus on payer mix, referral sources, and operational efficiency. Swiftly aggregate activity data to uncover valuable operational insights, enabling you to examine your information in innovative and meaningful ways. Experience rapid query results that allow for treatment or policy adjustments within hours instead of days. This empowers your patients to benefit from the collective experiences of previous patients. Additionally, our data specialists are available to assist you in seamlessly incorporating Varian into your existing workflow, ensuring that you can leverage the full power of your oncology data for improved patient care. With InSightive, the future of oncology data management is at your fingertips.
Description
Omda Cytodose, an oncology medication management solution from Omda, employs clinically validated protocols along with patient-specific parameters to ensure safer and more effective treatments for individuals battling cancer. This innovative system enhances the quality of care provided to oncology patients by fostering a seamless and collaborative treatment process among healthcare professionals, including doctors, pharmacists, and nurses. Omda Cytodose is designed to support a comprehensive range of adult and pediatric cancers, accommodating various medical treatments such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Initially created by a team of clinicians at one of Norway's premier cancer centers and introduced in 2001, Omda Cytodose has gained widespread adoption across healthcare regions in the Nordic countries, leading to the fulfillment of millions of medication orders. With a robust 15-year history marked by stability, reliability, and safety, the system is meticulously configured with chemotherapy protocols that reflect both national and international guidelines. This ensures that patients receive the most up-to-date treatment options available, further enhancing their chances of successful outcomes.
API Access
Has API
API Access
Has API
Integrations
Tableau
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Varian
Founded
1999
Country
United States
Website
www.varian.com/products/software/analytics/insightive
Vendor Details
Company Name
Omda
Founded
1999
Country
Norway
Website
omda.com/solutions/medication-management/omda-cytodose/